2 Monster Stocks Worth Holding for the Next Decade

Coca-Cola and Altria are highlighted as long-term income holdings, supported by 64 and 57 consecutive years of dividend increases, respectively. Coca-Cola is up 27.8% year-to-date and yields 2.3%, benefiting from an asset-light bottling model; Altria is up 20.5% year-to-date, up 75% since the start of 2024, and yields 6%. Altria continues to offset declining cigarette volumes through price increases while building smoke-free products, though the article notes this transition remains challenging.

Analysis

This is not a fresh fundamental catalyst; it reinforces a crowded quality-income positioning that leaves KO and MO more exposed to duration and valuation normalization than the article implies. KO’s concentrate model supports superior incremental margins, but its equity upside over the next 1-3 months depends on organic-sales/mix durability and FX rather than dividend credibility. At a premium multiple, even modest deceleration in pricing-led growth or a stronger dollar can compress the defensive premium.

MO’s yield is compensation for a shrinking combustible profit pool, not a free option on stability. Its near-term cash flow can remain resilient through price/mix, but 6-18 month downside is asymmetric if cigarette elasticity rises, excise taxes tighten, or smoke-free investment fails to offset volume decline; sustained payout growth then becomes a capital-allocation constraint. The more relevant competitive read-through is PM, whose international smoke-free scale offers a structurally cleaner nicotine transition, while BTI provides a cheaper but more leveraged regulatory-risk alternative.

Contrarian view: PEP is not necessarily the loser from KO’s margin advantage. PEP’s snack portfolio provides a different inflation and consumer-trade-down exposure, and its relative underperformance could create a valuation entry if beverage-margin concerns are already reflected. There is no actionable signal from the promotional framing alone; use upcoming earnings to test whether premium valuations remain supported by volume rather than price.

Key Decisions for Investors

• Do not add outright KO after the recent rerating; maintain only a market-weight defensive allocation. Reassess after the next earnings release: add on a 8-10% pullback only if unit-case volume is positive and full-year organic revenue guidance is maintained; reduce if growth is achieved primarily through price with volume turning negative.
• Express relative value over 3-6 months via long PEP / short KO in equal beta-weighted notional if the valuation gap remains elevated. Thesis: PEP’s snacks diversify category risk while KO is more exposed to FX and a premium-multiple reset; stop if KO delivers two consecutive quarters of accelerating volume growth and PEP cuts organic-sales guidance.
• Avoid chasing MO for yield; retain only as an income position with a 6-12 month monitoring trigger. Exit/reduce on a material payout-ratio increase, cigarette-volume deterioration beyond management’s expected range, or adverse FDA action on nicotine/product authorization; consider PM instead for investors requiring tobacco exposure with greater smoke-free optionality.
• Watch U.S. 10-year Treasury yields and consumer-staples relative performance over the next 1-3 months. A renewed yield backup is the clearest near-term catalyst for multiple compression in KO and MO despite otherwise stable operating results.